폐암과 동반되어 나타난 기관기관지병증 골연골형성증 1예

이영진,전현수,박시형,김모세,김현주,이승헌,이영민,이현욱,이현경 仁濟大學校 白病院 2010 仁濟醫學 Vol.31 No.-

Tracheobronchopathia osteochondroplastica (TPO) is a rare benign disease of unknown etiology characterized by multiple cartilaginous or bony submucosal nodules, which project into the tracheobronchial lumen. Although some disorders were reported combined with TPO, these seemed to be considered casual. We report a case of TPO that combined with adenocarcinoma of lung. She was 50-year-old non smoking woman presented with chronic cough with right chest pain. Lung mass on right lower lobe was found on chest x-ray, so lung cancer was suspected. Multiple scattered whitish small elevations from trachea to bronchial trees were found on bronchoscopic exam. We mistook these lesions for metastases from lung cancer and biopsies of these lesions were done. Transbronchial biopsy for right lower lobe mass lesion was also done. But biopsies from trachea and bronchus revealed TPO rather than lung cancer. Transbronchial lung biopsy of right lower lobe mass was diagnosed adenocarcinoma of lung. So TPO combined with adenocarcinoma of lung was diagnosed.

조혈모세포이식 환자에서 침습성 진균 감염에 대한 Micafungin의 예방 효과 및 안전성

김시현,이동건,최수미,권재철,박선희,최정현,유진홍,이성은,조병식,김유진,이석,김희제,민창기,조석구,김동욱,이종욱,민우성,박종원 대한감염학회 2010 감염과 화학요법 Vol.42 No.3

Background: Micafungin, a potent inhibitor of 1,3-β-D-glucan synthase, is a novel antifungal agent of the echinocandin class. In vitro study showed that micafungin was effective against Aspergillus species as well as Candida species, but clinical data on the prophylactic efficacy against invasive fungal infections (IFIs) other than candidiasis are still lacking. Materials and Methods: We identified 60 consecutive adult hematopoietic stem cell transplantation (HSCT) recipients who received at least 3 doses of micafungin during neutropenic period. Micafungin was started as an alternative in patients who were intolerant or had adverse events (AEs) to primary prophylactic antifungal agents. We retrospectively reviewed the medical records and analyzed the efficacy and safety of micafungin for prophylaxis against IFIs. Results: The patients either had autologous (n=9) or allogeneic (n=51: 1 syngeneic, 24 sibling, 26 unrelated donor) HSCT. Itraconazole oral solution (n=58) was the most frequently used first line antifungal agent for prophylaxis and was administered for median 11 days. The most frequent cause of switch to micafungin was vomiting (n=42). The duration of neutropenia and micafungin administration was median 13 and 12 days, respectively. A successful outcome was achieved in 45 (75%) patients. Empirical antifungal therapy was initiated in 13 (22%) patients. There were 2 cases (3.3%) of breakthrough fungal infections which comprised a probable invasive pulmonary aspergillosis and a possible invasive fungal sinusitis. There was no case of invasive candidiasis. A total of 53 (88%) patients experienced at least one AE regardless of causality during micafungin administration. The most frequent AEs were hypokalemia, vomiting, diarrhea, and elevated serum aspartate aminotransferase or alanine aminotransferase. Among the aforementioned AEs, only 1 case of diarrhea could be classified as a probable relation with micafungin when causality was assessed. There was no AEs that caused discontinuation of micafungin. Conclusions: Micafungin seems to be a safe and effective agent for prophylaxis of IFIs including aspergillosis as well as candidiasis in HSCT recipients. However, further large, prospective, and randomized comparative studies are warranted for aspergillosis.

조혈모세포이식 환자에서 발생한 Cytomegalovirus 질환의 특징 : 일개 대학변원에서 최근 10년간의 경험

최수미,이동건,박선희,김시현,김유진,민창기,김희제,이석,최정현,유진홍,김동욱,이종욱,민우성,신완식,김춘추 대한감염학회 2009 감염과 화학요법 Vol.41 No.1

Background : Studies on cytomegalovirus (CMV) diseases in Korean hematopoietic stem cell transplant (HSCT) recipients are lacking and do not reflect the recent trends of advances and changes. Therefore, we tried to analyze the clinical features of CMV diseases in HSCT recipients over the past 10 years at a tertiary university hospital in Korea. Methods : Retrospective review of medical records was done for all adult HSCT patients who received transplant at the Catholic HSCT Center from January 1998 to January 2008. Results : Forty-four cases (2.2%) of CMV diseases were identified. CMV pneumonia was diagnosed in 17 patients, retinitis in 16 patients, enterocolitis in 7 patients, esophagitis 1 patient, gastritis in 1 patient, duodenitis in 1 patient, and hepatitis in 1 patient. The median onset of symptom was 90 days after transplantation. Late CMV diseases accounted for 47.7%. CMV related death varied from 0 to 58.8% according to the involved organ. CMV retinitis was diagnosed relatively later in the course of transplantation mostly in patients who had chronic graft versus host disease (GVHD). On the contrary, CMV enterocolitis mainly occurred in patients who suffered from acute GVHD. The overall concurrent CMV reactivation was documented to be 63.6%: the concurrent CMV reactivation was observed only in 37.5% of patients with retinitis. Conclusions : We observed some differences in the pattern of CMV disease manifestation according to the involved organ and reconfirmed the fact that CMV pneumonia is the most common and fatal disease in HSCT recipients. Additionally, CMV retinitis was not uncommon in HSCT recipients. Since specific marker does not exist in predicting retinitis, regular ocular examination should be done thoroughly, especially in patients with chronic GVHD.

혈액 투석 환자에서 중심정맥 협착에 대한 스텐트 삽입술 : Wallstent Placement

임대승,노상필,이유선,정승현,김보영,이정우,강정아,김정희,이민수,정준용,최시완,정진옥,성인환,이강욱,신영태 충남대학교 의과대학 의학연구소 2002 충남의대잡지 Vol.29 No.1

Stenosis of central vein is a common complication arising after percutaneous subclavian vein catheter insertion performed for temporary vascular access in chronic renal failure patients undergoing hemodialysis. There are several treatment methods for the condition like percutaneous angioplasty(PTA), stent insertion, and surgery, but recent trend is toward PTA and stents. Among the patients diagnosed with chronic renal failure from March 1993 to May 2002 and undergoing hemodialysis through AV fistula, the 14 Patients in whom central vein stenosis arose were selected for the study. A total of 28 percutaneous interventions(5 PTA and 23 stent placement) were performed, and restenosis rate and the time taken till the restenosis in de novo lesions and instant lesions were compared. All 28 cases were operated successfully. The 14 cases that received both anigioplasty and stent placement initially. (de novo lesion : 14 cases), Among the 10 cases with de novo lesion that followed up more than 1 year, 3 cases are currently undergoing hemodialysis without restenosis, and the remaining 7 cases have recurred stenosis with the mean time to restenosis of 10.9 months. In the 7 cases in whom stenosis recurred, 11 interventions were done(instent lesion: 11 cases). 4 of these were using only ballon angioplasty with 100% restenosis rate and the mean time of 3 months until restenosis. The remaining 7 cases were using both balloon angioplasty and stent placement, also with 100% restenosis rate but with the mean time of 12 months until restenosis, which was later than the group receiving only balloon angioplasty. In treating the patients with central vein stenosis, stent placement seems to be more advantageous over PTA in terms of restenosis rate and the mean duration of patency. In the case of instent lesion, inserting the stent for the second time after stenosis recurred lengthened the duration of patency compared to performing balloon angioplasty alone.

Run-Length Algorithm을 이용한 2차원 바코드의 패턴 인식

이재균,김시우,이채욱 대구대학교 정보통신연구소 2006 情報通信硏究 Vol.4 No.1

후복막강내 발생한 Castleman병 1례

남성진,이동욱,박찬규,정시욱,김추성,조성래,구본천,양사규,이일웅,박정자 慶北大學校 醫科大學 1997 慶北醫大誌 Vol.38 No.2

Castleman' s disease is a rare, reactive lymphoid proliferation of unknown cause and pathogenesis. Depending on histololgic findings, it has been divided into two distinct histologic subtypes that include hyaline-vascular type(90%) and plasmacell type(10%). This disease occurs most commonly in mediastinal lymph nodes and cervical lymph nodes, inguinal lymph nodes respectively. But occurs rarely in retroperitoneum. We report a case of hyaline-vascular type asymptomatic Castleman' s disease of the retroperitoneum in a 47-year-old man.

여성 외음부에 발생한 비전형적인 기저세포암 1예

권지애,이상욱,김경문,김시용 대한피부과학회 2003 대한피부과학회지 Vol.41 No.12

Basal cell carcinoma(BCC)_s are most frequently found on the sun-exposed skin of the head and neck regions. Rarely, BCC_s occur in odd sites such as the scrotum, vulva, perineum, inpple, and axilla without any apparent carcinogenic factor such as arsenic, rediation, chronic ulceration or scars. Genital BCC accounts for fewer than 1% of all BCC_s and vulvar BCC_s represent fewer than 5% of all vulvar neoplasms. We report a case of BCC arising on the mons pubis clinically mimicking malignant melanoma, which presents with 2㎝ sized, deep purple colored protruding mass. (Korean J Dermatol 2003;41(12):1674~1676)

Double Gantzer’s Muscles by Four Muscle Bellies and Its Clinical Significance : A Case Report

Si-Wook Lee(이시욱),Jae-Ho Lee(이재호),Hyunsu Lee(이현수) 대한체질인류학회 2017 해부·생물인류학 (Anat Biol Anthropol) Vol.30 No.2

Gantzer근육은 아래팔에 있는 부수적인 근육으로, 긴엄지굽힘근과 깊은손가락굽힘근의 덧갈래 형태로 발견된다. 본 증례에서는 근육덩이 네 개로 이루어진 Gantzer근육 쌍을 보고하고자 한다. 본 증례의 Gantzer근육은 얕은손가락굽힘근의 등쪽에서부터 네 개의 근육덩이가 시작되어 두 개의 근육 쌍으로 합쳐지며 각각 긴엄지굽힘근과 깊은손가락굽힘근으로 닿는 양상이었다. 긴엄지굽힘근과 깊은손가락굽힘근의 덧갈래근육은 각각 정중신경과 자동맥을 교차했다. 이러한 형태의 아래팔근육변이는 드문 경우로서, 관련된 임상적, 발생학적 의의를 요약하였다. The Gantzer’s muscle (GM) is an additional muscle in the forearm as the accessory head of the flexor pollicis longus (FPL) and accessory head of the flexor digitorum profundus (FDP). We reported a rare case of double GM formed by four muscle bellies. From the dorsal part of flexor digitorum superficialis, small four bellies formed two muscles merging to FDP and FPL, as GMs. These accessory heads of FDP and FPL crossed the ulnar artery and the median nerve, respectively. These additional muscles in the forearm flexor compartment are rare and its clinical and embryological significances should be considered.

Geometric and dosimetric verification of a recurrent neural network algorithm to compensate for respiratory motion using an articulated robotic couch

Lee Minsik,Cho Min-Seok,Lee Hoyeon,Jeong Chiyoung,Kwak Jungwon,Jung Jinhong,Kim Su Ssan,Yoon Sang Min,Song Si Yeol,Lee Sang-wook,Kim Jong Hoon,Choi Eun Kyung,Cho Seungryong,Cho Byungchul 한국물리학회 2021 THE JOURNAL OF THE KOREAN PHYSICAL SOCIETY Vol.78 No.1

The purpose of this study is to evaluate the performance of a recurrent neural network (RNN)-based prediction algorithm to compensate for respiratory movement using an articulated robotic couch system. A prototype of a real-time respiratory motion compensation couch was built using an optical 3D motion tracking system and a six-degree-of-freedom-articulated robotic system. To compensate for the system latency from motion detection to re-positioning of the system, RNN and double exponential smoothing (ES2) prediction algorithms were applied. Three aspects of performance were evaluated, simulation and experiments for geometric and dosimetric evaluations, using data from three liver and three lung patients who underwent stereotactic body radiotherapy. Overall, the RNN algorithm showed better geometric and dosimetric results than the other approaches. In simulation tests, RNN showed 82% average improvement ratio, compared with non-predicted results. In the geometric evaluation, RNN only showed average FWHM broadening of 1.5 mm, compared with the static case. In the dosimetric evaluation, RNN showed average gamma passing rates of 97.4 ± 1.0%, 89.0 ± 2.4% under the 3%/3 mm, 2%/2 mm respectively. It may be technically feasible to use the RNN prediction algorithm to compensate for respiratory motion with an articulated robotic couch system. The RNN algorithm could be widely used for motion compensation in patients undergoing radiotherapy.

Microtubule Inhibitory Effects of Various SJ Compounds on Tissue Culture Cells

Lee Jong Han,Kang Dong Wook,Kwon Ho Suk,Lee Sun Hwan,Park Si Kyung,Chung Sun Gan,Chon Eui Hwan,Paik Soon Young,Lee Joo Hun The Pharmaceutical Society of Korea 2004 Archives of Pharmacal Research Vol.27 No.4

SJ compounds (SJ8002 and related compounds) are a group of novel anticancer agents (Cho, Chung, Lee, Kwon, Kang, Joo, and Oh. PCT/KR02/00392). To explore the anticancer mechanism of these compounds, we examined the effect of SJ8002 on microtubules of six human cell lines. At a high concentration ($2\;{\mu}g/mL$), SJ8002 effectively disrupted microtubules of the six cell lines within 1 h. At lower concentrations ($0.05\~1.0\;{\mu}g/mL$), the antimicrotubule activity of SJ8002 varied defending on cell lines. The inhibition of in vitro polymerization of pure tubulin by SJ8002 suggested that SJ8002 acts on free tubulin, inhibits the polymerization of tubulin dimer into microtubules, and hence induces the depolymerization of microtubules.